| Clem Melton Doxey, MD | |
|
7930 N Shadeland Ave, Indianapolis, IN 46250-2691 | |
| (317) 621-6725 | |
| (317) 621-4545 |
| Full Name | Clem Melton Doxey |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 37 Years |
| Location | 7930 N Shadeland Ave, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043244460 | NPI | - | NPPES |
| 100095160 | Medicaid | IN | |
| P01133599 | Other | IN | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 01041532 (Indiana) | Secondary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 01041532 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital North | Indianapolis, IN | Hospital |
| Community Hospital East | Indianapolis, IN | Hospital |
| Hancock Regional Hospital | Greenfield, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Physicians Of Indiana Inc | 1759416662 | 1319 |
News Archive
Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.
Sticky nanoparticles that deliver drugs precisely to their targets — and then stay there — could play a crucial role in fighting ovarian and uterine cancers.
In the largest and most reliable study of its type, the University of Oxford (UK) and the University of Sydney (Australia) have demonstrated that statin therapy is not a cause of increased cancer rates and deaths. The conclusions of this study will reassure the millions of people worldwide who are taking statins to lower cholesterol levels, and clarifies earlier research that had raised concerns of a causal link.
The study, which looked at 890 heart attack patients admitted to six major teaching hospitals in Dublin, Southern Ireland, also found that it took women five times as long as men to go to casualty departments after their symptoms first started. But only one per cent got behind the wheel and drove to the hospital.
Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.
› Verified 1 days ago
| Entity Name | Community Physicians Of Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619105244 PECOS PAC ID: 1759416662 Enrollment ID: O20100317000717 |
News Archive
Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.
Sticky nanoparticles that deliver drugs precisely to their targets — and then stay there — could play a crucial role in fighting ovarian and uterine cancers.
In the largest and most reliable study of its type, the University of Oxford (UK) and the University of Sydney (Australia) have demonstrated that statin therapy is not a cause of increased cancer rates and deaths. The conclusions of this study will reassure the millions of people worldwide who are taking statins to lower cholesterol levels, and clarifies earlier research that had raised concerns of a causal link.
The study, which looked at 890 heart attack patients admitted to six major teaching hospitals in Dublin, Southern Ireland, also found that it took women five times as long as men to go to casualty departments after their symptoms first started. But only one per cent got behind the wheel and drove to the hospital.
Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clem Melton Doxey, MD 6626 E 75th St, Suite 500, Indianapolis, IN 46250-2805 Ph: () - | Clem Melton Doxey, MD 7930 N Shadeland Ave, Indianapolis, IN 46250-2691 Ph: (317) 621-6725 |
News Archive
Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.
Sticky nanoparticles that deliver drugs precisely to their targets — and then stay there — could play a crucial role in fighting ovarian and uterine cancers.
In the largest and most reliable study of its type, the University of Oxford (UK) and the University of Sydney (Australia) have demonstrated that statin therapy is not a cause of increased cancer rates and deaths. The conclusions of this study will reassure the millions of people worldwide who are taking statins to lower cholesterol levels, and clarifies earlier research that had raised concerns of a causal link.
The study, which looked at 890 heart attack patients admitted to six major teaching hospitals in Dublin, Southern Ireland, also found that it took women five times as long as men to go to casualty departments after their symptoms first started. But only one per cent got behind the wheel and drove to the hospital.
Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.
› Verified 1 days ago
Heather Celia Williams, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8450 Northwest Blvd, Indianapolis, IN 46278 Phone: 317-802-2000 Fax: 317-802-2170 | |
Dr. Scott A Lintner, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8450 Northwest Blvd, Indianapolis, IN 46278 Phone: 317-802-2000 Fax: 317-802-2170 | |
Charles Philip Bartley Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5255 E Stop 11 Rd, Suite 300, Indianapolis, IN 46237 Phone: 317-528-4723 Fax: 317-528-4699 | |
Dr. Renn J Crichlow, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8402 Harcourt Rd, Indianapolis, IN 46260 Phone: 317-802-2000 | |
Mihir M Patel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8450 Northwest Blvd., Indianapolis, IN 46278 Phone: 317-802-2000 Fax: 317-802-2170 | |
Thomas Kyle Stoops, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1801 N Senate Blvd Ste 535, Indianapolis, IN 46202 Phone: 804-389-1025 | |
Aki Sefaro Puryear, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 705 Riley Hospital Dr, Indianapolis, IN 46202 Phone: 317-948-2550 |